The process of developing liposome formulations is intricate and iterative, requiring a profound understanding of the physicochemical properties of liposomes and their interactions with cells and tissues. One key advantage of liposomes lies in their ability to encapsulate both hydrophilic and hydrophobic drugs, enabling the co-delivery of multiple agents within a single formulation. This capability can significantly enhance combination therapies' effectiveness while reducing the need for multiple injections, thereby improving patient compliance. Moreover, by utilizing ligands or nanoparticles, liposomes can be targeted toward specific cells or tissues for site-specific drug delivery. This targeted approach not only reduces systemic toxicity but also enhances the therapeutic window for drugs. The development of liposome formulations holds immense significance in the realm of human health. In medicine, it is anticipated to assume a pivotal role in the treatment and prevention of various diseases; concurrently, it finds extensive application in the domains of cosmetics and nutritional supplements.